PMID- 27338645 OWN - NLM STAT- MEDLINE DCOM- 20170529 LR - 20180103 IS - 1096-0333 (Electronic) IS - 0041-008X (Linking) VI - 305 DP - 2016 Aug 15 TI - Suppressed osteoclast differentiation at the chondro-osseous junction mediates endochondral ossification retardation in long bones of Wistar fetal rats with prenatal ethanol exposure. PG - 234-241 LID - S0041-008X(16)30155-7 [pii] LID - 10.1016/j.taap.2016.06.021 [doi] AB - Prenatal ethanol exposure (PEE) inhibits longitudinal growth of fetal bones, but the underlying mechanisms remain unknown. In this study, we aimed to investigate how PEE induces the retardation of long bone development in fetal rats. Pregnant Wistar rats were treated with ethanol or distilled water (control group) by gavage from gestational day (GD) 9 to 20. Fetuses were delivered by cesarean section on GD20. Fetal sera were collected for assessing corticosterone (CORT) level. Fetal long bones were harvested for histochemical, immunohistochemical and gene expression analysis. Primary chondrocytes were treated with ethanol or CORT for analyzing genes expression. PEE fetuses showed a significant reduction in birth weight and body length. The serum CORT concentration in PEE group was significantly increased, while the body weight, body length and femur length all were significantly decreased in the PEE group. The length of the epiphyseal hypertrophy zone was enlarged, whereas the length of the primary ossification center was significantly reduced in PEE fetuses. TUNEL assay showed reduced apoptosis in the PEE group. Further, the gene expression of osteoprotegerin (OPG) was markedly up-regulated. In vitro experiments showed that CORT (but not ethanol) treatment significantly activated the expression of OPG, while the application of glucocorticoid receptor inhibitor, mifepristone, attenuated these change induced by CORT. These results indicated that PEE-induced glucocorticoid over-exposure enhanced the expression of OPG in fetal epiphyseal cartilage and further lead to the suppressed osteoclast differentiation in the chondro-osseous junction and consequently inhibited the endochondral ossification in long bones of fetal rats. CI - Copyright (c) 2016 Elsevier Inc. All rights reserved. FAU - Pan, Zhengqi AU - Pan Z AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China. FAU - Zhang, Xianrong AU - Zhang X AD - Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China. FAU - Shangguan, Yangfan AU - Shangguan Y AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China. FAU - Hu, Hang AU - Hu H AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China. FAU - Chen, Liaobin AU - Chen L AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China. Electronic address: lbchen@whu.edu.cn. FAU - Wang, Hui AU - Wang H AD - Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China. Electronic address: wanghui19@whu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20160623 PL - United States TA - Toxicol Appl Pharmacol JT - Toxicology and applied pharmacology JID - 0416575 RN - 3K9958V90M (Ethanol) SB - IM MH - Animals MH - Cell Differentiation/drug effects MH - Cells, Cultured MH - Chondrocytes/drug effects/physiology MH - Ethanol/*toxicity MH - Female MH - Femur/*drug effects/growth & development MH - Fetus MH - Osteoclasts/drug effects/physiology MH - Osteogenesis/*drug effects MH - Pregnancy MH - *Prenatal Exposure Delayed Effects MH - Rats, Wistar OTO - NOTNLM OT - Endochondral ossification retardation OT - Osteoclast OT - Osteoprotegerin (OPG) OT - Prenatal ethanol exposure OT - Receptor activator for nuclear factor-kappab ligand (RANKL) EDAT- 2016/06/25 06:00 MHDA- 2017/05/30 06:00 CRDT- 2016/06/25 06:00 PHST- 2016/04/12 00:00 [received] PHST- 2016/06/17 00:00 [revised] PHST- 2016/06/18 00:00 [accepted] PHST- 2016/06/25 06:00 [entrez] PHST- 2016/06/25 06:00 [pubmed] PHST- 2017/05/30 06:00 [medline] AID - S0041-008X(16)30155-7 [pii] AID - 10.1016/j.taap.2016.06.021 [doi] PST - ppublish SO - Toxicol Appl Pharmacol. 2016 Aug 15;305:234-241. doi: 10.1016/j.taap.2016.06.021. Epub 2016 Jun 23.